United Therapeutics

$0.00 (0.00%) As of 12:18 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UTHR and other ETFs, options, and stocks.

About UTHR

United Therapeutics Corp. operates as a biotechnology company engaged in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma.

CEO
Martine A. Rothblatt
Employees
965
Headquarters
Silver Spring, Maryland
Founded
1996

UTHR Key Statistics

Market cap
8.53B
Price-Earnings ratio
13.04
Dividend yield
—
Average volume
466.86K
High today
$188.88
Low today
$184.61
Open price
$188.07
Volume
465.76K
52 Week high
$218.38
52 Week low
$158.38

UTHR News

BenzingaMay 18

United Therapeutics's Return on Invested Capital Insights

According to Benzinga Pro, during Q1, United Therapeutics UTHR earned $239.90 million, a 113.81% increase from the preceding quarter. United Therapeutics also p

UTHR Earnings

$0.00
$1.68
$3.35
$5.03
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure